Thyroid and COVID-19. Review and recommendations for patients with thyroid disease
DOI:
https://doi.org/10.21615/cesmedicina.34.COVID-19.11Keywords:
COVID-19, SARS-CoV-2, Hypothyroidism, Hyperthyroidism, Thyroid cancerAbstract
Both benign and malignant thyroid diseases are highly prevalent Worldwide, so it is highly likely that during the COVID-19 pandemic we will see patients with this comorbidity. This requires knowledge of the potential implications of this new virus in the functioning of the gland, the usual treatments for these diseases and special recommendations in this population. To date, there is no evidence to support that thyroid diseases increase the risk of infection or the disease severity. However, it is possible that during se vere SARS-CoV-2 infections in people with or without history of thyroid disease, the thyroid tests may be altered, although transitory and does not require specific treatment. It is essential for patients to continue with their outpatient treatments and defer as far as possible surgical procedures or administration of radioactive iodine until it is considered safe to perform.
Downloads
References
Desailloud R, Hober D. Viruses and thyroiditis: an update. Virol J. 2009;6:5.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 12 de marzo de 2020;94:91-5.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA. 7 de febrero de 2020;323(11):1061-1069.
Gupta N, Agrawal S, Ish P, Mishra S, Gaind R, Usha G, et al. Clinical and epidemiologic profile of the initial COVID-19 patients at a tertiary care centre in India. Monaldi Arch Chest Dis Arch Monaldi Mal Torace. 10 de abril de 2020;90(1).
Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 10 de abril de 2020;58 (7):1021-1028.
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 26 de 2020;368:m1091.
Wang W., Ye Y.X., Yao H. Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chin Antituberculous Assoc. 2003;25:232–234.
Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. junio de 2004;203(2):622-30.
Wei L, Sun S, Xu C, Zhang J, Xu Y, Zhu H, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol [Internet]. enero de 2007 [citado 11 de mayo de 2020];38(1):95-102. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112059/
Wei L, Sun S, Zhang J, Zhu H, Xu Y, Ma Q, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol [In ternet]. 2010 ;88(4):723-30. Disponible en: https://www.nrcresearchpress.com/doi/10.1139/O10-022
Ye YX, Wang W, Yao H, Li HM, Sun LQ, Wang AS, et al. Change in hormones of related sexual function in patients with severe acute respiratory syndrome. Labeled Immunoass Clin Med. 2004;11:63-5.
Leow MK, Kwek DS, Ng AW, Ong K, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) [Internet]. 2005 [citado 11 de mayo de 2020];63(2):197-202. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188349/
Chrousos GP, Kaltsas G. Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what? Clin Endocrinol (Oxf) [Internet]. 2005 [citado 11 de mayo de 2020];63(4):363-5. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162060/
Boelaert K, Visser WE, Taylor PN, Moran C, Léger J, Persani L. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020;183(1):G33-9.
American Thyroid Association. Novel Coronavirus (COVID-19) and the Thyroid: Frequently Asked Questions [Internet]. American Thyroid Association. [citado 27 de julio de 2020]. Disponible en: https://www.thyroid.org/covid-19/coronavirus-frequently-asked-questions/
British Thyroid Foundation. Thyroid disease and coronavirus (COVID-19) [Internet]. British Thyroid Foundation. [citado 27 de julio de 2020]. Disponible en: https://www.btf-thyroid.org/news/thyroid-disease-and-coronavirus-covid-19
Sociedad Española de Endocrinología, y Nutrición (SEEN). Posicionamiento del Área de Conocimiento de Tiroides de la Sociedad Española de Endocrinología y Nutrición (SEEN) sobre los efectos de la pandemia de COVID-19 sobre las enfermedades tiroideas [Internet]. Disponible en: https://www.seen.es/ModulGEX/workspace/publico/modulos/web/docs/apartados/1091/150420_104500_4745077698.pdf
Vrachimis A, Iakovou I, Giannoula E, Giovanella L. Endocrinology in the time OF COVID-19: Management of thyroid nodules and cancer. Eur J Endocrinol. julio de 2020;183(1):G41-8.
American Thyroid Association. Clinical Affairs Committee: Physician Guidance to Thyroid FNA during COVID-19 crisis [Internet]. American Thyroid Association. [citado 27 de julio de 2020]. Disponible en: https://www.thyroid.org/covid-19/clinical-committee-physician-guidance/
British Thyroid Foundation. Thyroid cancer and coronavirus (COVID-19) [Internet]. British Thyroid Foundation. [citado 27 de julio de 2020]. Disponible en: https://www.btf-thyroid.org/thyroid-cancer-and-coronavirus
Metzger R, Singer M. Comment on Thyroid Surgery During the Covid-19 Pandemic [Internet]. American Thyroid Association: Comment on Thyroid Surgery During the Covid-19 Pandemic. [citado 5 de junio de 2020]. Disponible en: https://www.thyroid.org/covid-19/comment-on-thyroid-surgery-during-pandemic
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 CES Medicina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos de reproducción (copyright)
Cada manuscrito se acompañará de una declaración en la que se especifique que los materiales son inéditos, que no han sido publicados anteriormente en formato impreso o electrónico y que no se presentarán a ningún otro medio antes de conocer la decisión de la revista. En todo caso, cualquier publicación anterior, sea en forma impresa o electrónica, deberá darse a conocer a la redacción por escrito.
Plagios, duplicaciones totales o parciales, traduccones del original a otro idioma son de responsabilidad exclusiva de los autores el envío.
Los autores adjuntarán una declaración firmada indicando que, si el manuscrito se acepta para su publicación, los derechos de reproducción son propiedad exclusiva de la Revista CES Medicina.
Se solicita a los autores que proporcionen la información completa acerca de cualquier beca o subvención recibida de una entidad comercial u otro grupo con intereses privados, u otro organismo, para costear parcial o totalmente el trabajo en que se basa el artículo.
Los autores tienen la responsabilidad de obtener los permisos necesarios para reproducir cualquier material protegido por derechos de reproducción. El manuscrito se acompañará de la carta original que otorgue ese permiso y en ella debe especificarse con exactitud el número del cuadro o figura o el texto exacto que se citará y cómo se usará, así como la referencia bibliográfica completa.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
